CompletedPhase 3NCT01295710
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Studying Rare disorder potentially indicated for transplant or complication after transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Neovii Biotech
- Principal Investigator
- Anne KuanNeovii Biotech
- Intervention
- US-ATG-F(biological)
- Enrollment
- 260 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2011 – 2015
Study locations (28)
- City of Hope, Duarte, California, United States
- Stanford University Medical Center, BMT, Stanford, California, United States
- University of Florida Shands Cancer Center, Gainesville, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- University of Chicago Medical Center, Chicago, Illinois, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- University of Kansas Medical Center, Westwood, Kansas, United States
- Tulane University Health Sciences Center, New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Washington University Medical Center, St Louis, Missouri, United States
- Weill Cornell Medical Center, New York, New York, United States
- University of North Carolina Hospitals, Chapel Hill, North Carolina, United States
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01295710 on ClinicalTrials.govOther trials for Rare disorder potentially indicated for transplant or complication after transplantation
Additional recruiting or active studies for the same condition.